Variant report
Variant | esv3322405 |
---|---|
Chromosome Location | chr11:109020592-109021690 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556224775 | chr11:109020597-109020598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565635600 | chr11:109020651-109020652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376916228 | chr11:109020653-109020654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545082485 | chr11:109020697-109020698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539422450 | chr11:109020762-109020763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560342927 | chr11:109020791-109020792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527876119 | chr11:109020822-109020823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549449242 | chr11:109020857-109020858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561585647 | chr11:109020890-109020891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531210263 | chr11:109020894-109020895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10789716 | chr11:109020953-109020954 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs139358890 | chr11:109020955-109020956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565324617 | chr11:109020997-109020998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571383177 | chr11:109021031-109021032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143265893 | chr11:109021059-109021060 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547496170 | chr11:109021086-109021087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147535058 | chr11:109021167-109021168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564781336 | chr11:109021227-109021228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139766787 | chr11:109021244-109021245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536437210 | chr11:109021248-109021249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554576198 | chr11:109021259-109021260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569886174 | chr11:109021267-109021268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138334417 | chr11:109021337-109021338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374710832 | chr11:109021352-109021353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556554069 | chr11:109021385-109021386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569745612 | chr11:109021426-109021427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373166827 | chr11:109021429-109021430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10890953 | chr11:109021511-109021512 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs545144424 | chr11:109021515-109021516 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556652476 | chr11:109021521-109021522 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371404978 | chr11:109021580-109021581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553837225 | chr11:109021581-109021582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547904955 | chr11:109021612-109021613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568949567 | chr11:109021656-109021657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:109012000-109021200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr11:109012000-109021400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr11:109019000-109020600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr11:109020200-109021200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr11:109020600-109021000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr11:109021000-109021200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr11:109021000-109021600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr11:109021200-109021400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr11:109021200-109021600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr11:109021200-109021600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr11:109021200-109021600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr11:109021400-109021600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr11:109021400-109021600 | Enhancers | Aorta | Aorta |
14 | chr11:109021400-109021800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr11:109021400-109022200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |